RxDoctor Payments Data

Michael Chaikel, PA

Physician Assistant · Wilmington, DENPI 1871572776

Payments from drug & device makers

$636in general payments, 2019–2025

Across 8 payments — averaging $79.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Verona Pharma, Inc.$125
  • Gilead$125
  • Boehringer Ingelheim$125
  • Novo Nordisk$121
  • Bayer$77
  • Pfizer$29
  • plus $34 from 2 others

What the payments were for

  • Food & beverage$636100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Verona Pharma, Inc.1$125
Gilead1$125
Boehringer Ingelheim1$125
Novo Nordisk1$121
Bayer1$77
Pfizer1$29
Amgen1$20
AstraZeneca1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$636 in reported general payments places this provider in the 70th percentile of 527 physician assistant providers in Delaware.

See all physician assistant providers in Delaware

Medicare billing

Part B allowed, 2024
$86,494
Medicare patients
709
Services billed
1,054

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin64$763
Albuterol Sulfate HfaAlbuterol Sulfate18$482
Ciprofloxacin Hcl55$398
Azithromycin69$370
Mupirocin14$227
Naproxen69$227
Clindamycin Hcl16$216
Methylprednisolone26$189
Amoxicillin42$148
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$146
Doxycycline Hyclate22$136
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst11$120
Cyclobenzaprine Hcl21$109
Prednisone49$89
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen21$70

Paid to pharmacies, not to this prescriber.

Other physician assistant in Wilmington

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →